Predictors of impact of vaginal symptoms in postmenopausal women

被引:28
|
作者
Hunter, Mary M. [1 ]
Nakagawa, Sanae [2 ]
Van Den Eeden, Stephen K. [3 ]
Kuppermann, Miriam [2 ]
Huang, Alison J. [2 ,4 ]
机构
[1] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, 2 Koret Way,Box 0610, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Kaiser Permanente No Calif, Dept Urol, Div Res, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
Vaginal dryness; Vulvovaginal atrophy; Depression; Urinary incontinence; Menopausal symptoms; MENOPAUSAL SYMPTOMS; URINARY-INCONTINENCE; UROGENITAL SYMPTOMS; SEXUAL FUNCTION; HEALTH; MULTIMORBIDITY; DEPRESSION; DISCOMFORT; NATION; COHORT;
D O I
10.1097/GME.0000000000000482
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study aims to identify factors associated with greater impact of vaginal symptoms on the functioning and well-being of postmenopausal women. Methods: Postmenopausal women who reported vaginal dryness, itching, irritation, or pain with sexual activity completed the multidimensional Day-to-day Impact of Vaginal Aging (DIVA) questionnaire and underwent assessment of multiple sociodemographic and clinical factors that have the potential to influence the impact of vaginal symptoms. Multivariable linear regression analyses examined relationships between selected participant characteristics and DIVA scale scores assessing symptom impact on activities of daily living, emotional well-being, self-concept and body image, and sexual functioning. Results: Among 745 symptomatic participants, the mean (SD) age was 56 (9) years, and 66% were racial/ethnic minorities. Women with comorbid depression reported greater impact of vaginal symptoms on all dimensions of functioning and well-being measured by the DIVA questionnaire (11%-22% estimated increase in impact scores associated with every three-point increase in Hospital and Anxiety Depression Scale scores). Women with urinary incontinence also reported greater impact of vaginal symptoms on activities of daily living, emotional well-being, and self-concept and body image (27%-37% estimated increase in impact scores). Age, partner status, frequency of sexual activity, general health, and body mass index also predicted greater impact on at least one domain. Conclusions: Findings suggest that special efforts should be made to identify and treat vaginal symptoms in postmenopausal women known to have depression or urinary incontinence, as these women may experience greater impact of vaginal symptoms on multiple domains of functioning and quality of life.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [31] Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
    Sarmento, Ayane Cristine
    Fernandes, Fabiola Sephora
    Marconi, Camila
    Giraldo, Paulo Cesar
    Eleuterio-Junior, Jose
    Crispim, Janaina C.
    Goncalves, Ana Katherine
    CLINICS, 2020, 75 : 1 - 6
  • [32] TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women
    Simon, J. A.
    Kagan, R.
    Archer, D. F.
    Constantine, G. D.
    Bernick, B.
    Graham, S.
    Mirkin, S.
    CLIMACTERIC, 2019, 22 (04) : 412 - 418
  • [33] The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women
    Khapre, Shrutika
    Deshmukh, Ujjwala
    Jain, Sheela
    JOURNAL OF MID-LIFE HEALTH, 2022, 13 (02) : 175 - 184
  • [34] Effectiveness of vaginal estriol with lactobacilli on urinary symptoms in postmenopausal women: a randomized-controlled trial
    Jongjakapun, Apiwat
    Somboonporn, Woraluk
    Temtanakitpaisan, Teerayut
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (04): : 441 - 446
  • [35] Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms
    Thomas-White, Krystal
    Taege, Susanne
    Limeira, Roberto
    Brincat, Cynthia
    Joyce, Cara
    Hilt, Evann E.
    Mac-Daniel, Laura
    Radek, Katherine A.
    Brubaker, Linda
    Mueller, Elizabeth R.
    Wolfe, Alan J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (05) : 727.e1 - 727.e11
  • [37] Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors
    Huang, Alison J.
    Moore, Elya E.
    Boyko, Edward J.
    Scholes, Delia
    Lin, Feng
    Vittinghoff, Eric
    Fihn, Stephan D.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (01): : 121 - 126
  • [38] Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy
    Bachmann, G.
    Bobula, J.
    Mirkin, S.
    CLIMACTERIC, 2010, 13 (02) : 132 - 140
  • [39] EFFECT OF VAGINAL ESTRIOL ON MOOD DISORDER SYMPTOMS IN POSTMENOPAUSAL WOMEN WITH DYSPAREUNIA: A RANDOMIZED CLINICAL TRIAL
    De Paula, S. R.
    Carneiro, P. Sanches
    Okano, S. Henrique Pires
    Mendes, M. C.
    Da Silva, L. Alves
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [40] Effects of vaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with prolapse undergoing surgery
    Rahn, D. D.
    Richter, H. E.
    Sung, V.
    Hynan, L.
    Pruszynski, J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (03) : S809 - S810